Anavex Life Sciences Reports Fiscal Year 2019 Financial Results And Provides Clinical Study Updates
Anavex Life Sciences Reports Fiscal Year 2019 Financial Results And Provides Clinical Study Updates Conference Call and Webcast Today at 4:30 p.m. ET NEW YORK – December 16, 2019 – Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative…